Can-Fite BioPharma American Depositary Shares
CANF
12 hedge funds and large institutions have $186K invested in Can-Fite BioPharma American Depositary Shares in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 12 → 12 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
88% less capital invested
Capital invested by funds: $1.52M → $186K (-$1.33M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$51.1K |
| 2 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$20.2K |
| 3 |
KBFS
Kohmann Bosshard Financial Services
Fairlawn,
Ohio
|
+$6.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.31M |
| 2 |
Morgan Stanley
New York
|
-$36.8K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$20.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $52.8K | -$36.8K | -907 | -36% |
|
|
2
RhumbLine Advisers
Boston,
Massachusetts
| $43.7K | +$20.2K | +497 | +59% |
|
|
3
BNP Paribas Financial Markets
Paris,
France
| $40.9K | +$51.1K | +1,259 | New |
|
|
TSS
4
Two Sigma Securities
New York
| $31.5K | -$20.6K | -509 | -34% |
|
|
KBFS
5
Kohmann Bosshard Financial Services
Fairlawn,
Ohio
| $5.53K | +$6.9K | +170 | New |
|
6
Fifth Third Bancorp
Cincinnati,
Ohio
| $4.88K | – | – | – |
|
7
Wells Fargo
San Francisco,
California
| $4.06K | – | – | – |
|
8
National Bank of Canada
Montreal,
Quebec, Canada
| $975 | – | – | – |
|
9
Citigroup
New York
| $899 | – | – | – |
|
|
AWM
10
Activest Wealth Management
Aventure,
Florida
| $325 | – | – | – |
|
11
Osaic Holdings
Scottsdale,
Arizona
| $293 | – | – | – |
|
|
TWC
12
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $32 | – | – | – |
|
|
SS
13
SBI Securities
Tokyo,
Japan
| $2 | – | – | – |
|
|
AC
14
Armistice Capital
New York
| – | -$1.31M | -32,500 | Closed |
|
CANF Hedge Fund Activity: Q4 2024 in Review
12 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q4 2024, worth a combined $186K — down 88% from $1.52M a quarter earlier.
Fund positioning in CANF was balanced in Q4 2024: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was BNP Paribas Financial Markets, opening a new position worth an estimated $51.1K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.31M sold.
- 12 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $186K of Can-Fite BioPharma American Depositary Shares stock for Q4 2024, down 88% quarter-over-quarter.
- 2 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q4 2024 and 2 closed out, a net change of 0 holders.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q4 2024 was BNP Paribas Financial Markets, an estimated $51.1K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q4 2024 was Armistice Capital, an estimated $1.31M sold.
Based on aggregated 13F filings for Q4 2024.